| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07599384 Emulation of the RECORD3 Trial Using Healthcare Claims Data |
Primary endpoint(s) modified |
| 2026-06-05 | NCT05735639 THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) |
Enrollment reduced: 6660 -> 3175 participants |
| 2026-06-03 | NCT07312851 A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-30 | NCT07493304 Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants… |
Recruitment opened |
| 2026-05-27 | NCT05038228 High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial… |
date change Primary completion pushed: 2026-04-08 -> 2026-05-29 |
| 2026-05-27 | NCT05038228 High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial… |
date change Completion pushed: 2026-04-08 -> 2026-05-29 |
| 2026-05-27 | NCT04618913 Anticoagulation in Patients With Venous Thromboembolism and Cancer |
date change Primary completion pushed: 2026-04-06 -> 2026-06-30 |
| 2026-05-27 | NCT04618913 Anticoagulation in Patients With Venous Thromboembolism and Cancer |
date change Completion pushed: 2026-04-06 -> 2026-06-30 |
| 2026-05-23 | NCT07318610 Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With… |
Recruitment opened |
| 2026-05-23 | NCT07318610 Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With… |
date change Primary completion pushed: 2029-05-05 -> 2029-08-18 |
| 2026-05-23 | NCT07318610 Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With… |
date change Completion pushed: 2029-08-03 -> 2029-11-16 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07626411 Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation | Phase 3 | Not Yet Recruiting |
| 2026-06-01 | NCT07618858 Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration | Not Yet Recruiting | |
| 2026-06-01 | NCT07618988 Rivaroxaban in Pediatric Patients With DVT | Phase 4 | Completed |
| 2026-05-29 | NCT07613840 Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease | Recruiting | |
| 2026-05-27 | NCT07609654 Oral Anticoagulation After Stroke With Prior ICH in Subjects With AF | Phase 4 | Not Yet Recruiting |
| 2026-05-27 | NCT07609771 Heparin to Prevent Organ Failure in Acute Pancreatitis | Phase 4 | Not Yet Recruiting |
| 2026-05-22 | NCT07602062 Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal… | Not Yet Recruiting | |
| 2026-05-20 | NCT07599384 Emulation of the RECORD3 Trial Using Healthcare Claims Data | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT03968393 | Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial… | Stroke | Recruiting |
| NCT07404436 | Rivaroxaban in Idiopathic Membranous Nephropathy | Idiopathic Membranous Nephropathy | Recruiting |
| NCT06650501 | Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia | Staphylococcus Aureus Endocarditis | Recruiting |
| NCT07511257 | Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary… | Coronary Artery Ectasia | Recruiting |
| NCT07521332 | Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Cirrhosis | Recruiting |
| NCT06212674 | Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage… | Ischemic Stroke | Recruiting |
| NCT04642430 | COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial… | Atrial Fibrillation | Recruiting |
| NCT04263038 | Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated… | Pulmonary Embolism | Recruiting |
| NCT05735639 | THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) | Venous Thromboembolism | Recruiting |
| NCT06486792 | Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation | Stroke | Recruiting |
| NCT06396858 | Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban… | Ischemic Stroke | Not Yet Recruiting |
| NCT07404345 | Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent… | Hemodialysis Access Failure | Not Yet Recruiting |
| NCT03950076 | EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) | Intracranial Hemorrhages | Active, Not Recruiting |
| NCT06953726 | Comparing the Safety and Efficacy of Apixaban and Rivaroxaban | Atrial Fibrillation | Not Yet Recruiting |
| NCT07609654 | Oral Anticoagulation After Stroke With Prior ICH in Subjects With AF | Acute Ischemic Stroke | Not Yet Recruiting |
| NCT07609771 | Heparin to Prevent Organ Failure in Acute Pancreatitis | Acute Pancreatitis (AP) | Not Yet Recruiting |
| Phase 3 | |||
| NCT06370273 | Thromboprophylaxis in Lower Limb Immobilisation | Thrombosis | Recruiting |
| NCT07005024 | DOAC - Dosing Options in AntiCoagulation Prophylaxis | Cancer | Recruiting |
| NCT04374799 | Heparin vs Placebo for Cardiac Catheterization | Cardiac Disease | Recruiting |
| NCT05198960 | AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic… | Polycythemia Vera | Recruiting |
| NCT03243175 | Avoiding Anticoagulation After IntraCerebral Haemorrhage | Intracerebral Hemorrhage | Recruiting |
| NCT05848713 | AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired… | Community-acquired Pneumonia | Recruiting |
| NCT07015905 | REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee… | Venous Thromboembolism (VTE) | Recruiting |
| NCT03907046 | Anticoagulation in ICH Survivors for Stroke Prevention and Recovery | Intracerebral Hemorrhage | Recruiting |
| NCT06822426 | Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream… | Central Line Associated Blood Stream Infections (CLABSI) | Recruiting |